octyl gallate has been researched along with Alzheimer Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koyama, N; Maeda, M; Mori, T; Segawa, T; Tan, J; Town, T | 1 |
Fernandez, F; Giunta, B; Hou, H; Li, S; Mori, T; Rezai-Zadeh, K; Sawmiller, D; Shytle, D; Tan, J; Zhang, SQ; Zhou, S | 1 |
2 other study(ies) available for octyl gallate and Alzheimer Disease
Article | Year |
---|---|
Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Cognition; Coumaric Acids; Disease Models, Animal; Drug Therapy, Combination; Gallic Acid; Humans; Mice; Mice, Transgenic | 2017 |
Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Topics: ADAM Proteins; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Enzyme Activation; Estrogen Receptor alpha; Female; Gallic Acid; Humans; Male; Membrane Proteins; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Proteolysis; Proto-Oncogene Proteins c-akt; Signal Transduction | 2013 |